Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.Mov Disord. 1993 Apr; 8(2):195-7.MD
Abstract
The motor effects of the partial dopamine agonist EMD 49980 were evaluated in parkinsonian patients under controlled conditions. EMD 49980 monotherapy resulted in a mild improvement in parkinsonian symptoms, but when co-administered with levodopa, had no significant effect on dyskinesias or on the antiparkinsonian effect of the dopamine precursor. These results suggest that EMD 49980 exerts a net weak dopamine agonist effect but fails to ameliorate levodopa-induced dyskinesias.
MeSH
Pub Type(s)
Clinical Trial
Journal Article
Randomized Controlled Trial
Language
eng
PubMed ID
8097280
Citation
Bravi, D, et al. "Treatment of Parkinson's Disease With the Partial Dopamine Agonist EMD 49980." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 8, no. 2, 1993, pp. 195-7.
Bravi D, Davis TL, Mouradian MM, et al. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980. Mov Disord. 1993;8(2):195-7.
Bravi, D., Davis, T. L., Mouradian, M. M., & Chase, T. N. (1993). Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980. Movement Disorders : Official Journal of the Movement Disorder Society, 8(2), 195-7.
Bravi D, et al. Treatment of Parkinson's Disease With the Partial Dopamine Agonist EMD 49980. Mov Disord. 1993;8(2):195-7. PubMed PMID: 8097280.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.
AU - Bravi,D,
AU - Davis,T L,
AU - Mouradian,M M,
AU - Chase,T N,
PY - 1993/4/1/pubmed
PY - 1993/4/1/medline
PY - 1993/4/1/entrez
SP - 195
EP - 7
JF - Movement disorders : official journal of the Movement Disorder Society
JO - Mov Disord
VL - 8
IS - 2
N2 - The motor effects of the partial dopamine agonist EMD 49980 were evaluated in parkinsonian patients under controlled conditions. EMD 49980 monotherapy resulted in a mild improvement in parkinsonian symptoms, but when co-administered with levodopa, had no significant effect on dyskinesias or on the antiparkinsonian effect of the dopamine precursor. These results suggest that EMD 49980 exerts a net weak dopamine agonist effect but fails to ameliorate levodopa-induced dyskinesias.
SN - 0885-3185
UR - https://www.unboundmedicine.com/medline/citation/8097280/Treatment_of_Parkinson's_disease_with_the_partial_dopamine_agonist_EMD_49980_
L2 - https://doi.org/10.1002/mds.870080214
DB - PRIME
DP - Unbound Medicine
ER -